🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate whether specific lipoprotein(a) apheresis on the top of optimal...
Status
Completed
Location
Russian Cardiology Research and Production Center
Start Date
2009-09
Trial ID
NCT02133807
Treatments Being Tested
In patients with septic shock, low levels of circulating immunoglobulins ar...
Status
Unknown
Location
ICU- University Hospital Modena
Start Date
2020-05-01
Trial ID
NCT04182737
The purpose of this study is to prolong the time to reinfection with Pseudo...
Status
Completed
Location
Medizinische Universität Innsbruck Department für Kinderheilkunde, Päd III CF Zentrum
Start Date
2011-10
Trial ID
NCT01455675
T cell directed therapy, anti-thymocyte globulin (ATG), in low doses, has b...
Status
Recruiting
Location
Barbara Davis Center for Diabetes
Start Date
2025-11-12
Trial ID
NCT06455319
Treatments Being Tested
This multi-center randomized controlled trial will assess the safety and ef...
Status
Recruiting
Location
UCSF
Start Date
2026-03-10
Trial ID
NCT07061574
Treatments Being Tested
The purpose of this study is to investigate, if Immunoadsorption of autoant...
Status
Withdrawn
Location
Ernst Moritz Arndt Universität Greifswald
Start Date
2009-10
Trial ID
NCT01126411
Treatments Being Tested
Currently, there are no licensed therapeutics against Zika virus infection....
Status
Completed
Location
Syneos Health, Early Phase
Start Date
2018-06-27
Trial ID
NCT03624946
Treatments Being Tested
iMS-LC Assay (intact M-protein Screening-Light Chain Assay) is a new techno...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2024-07
Trial ID
NCT06489613
Treatments Being Tested
Methodology: This is a controlled, randomized, multicenter open-label Phas...
Status
Unknown
Location
Hospital El Pilar
Start Date
2020-12-01
Trial ID
NCT04537130
Treatments Being Tested
Polyclonal hypergammaglobulinaemia is characterized by increased levels of ...
Status
Unknown
Location
CHU Amiens
Start Date
2023-07-27
Trial ID
NCT06054373